Samsung, Massachusetts General Hospital team up to study GLP-1 muscle loss
Galaxy Watch wearers will get alerts about health and exercise to see if they can maintain their strength.
Latest news and analysis on pharma from Healthcare Brew, covering the key trends and regulatory shifts impacting the industry.
Galaxy Watch wearers will get alerts about health and exercise to see if they can maintain their strength.
The pilot program is starting in nine states.
Mark Cuban recently told Healthcare Brew the costs “kill the economics” for drugmakers like his.
The FDA announced its idea for speedier drug approvals on April 28.
Cheaper options may grant many more patients worldwide access to GLP-1s.
We may be getting closer to the first FDA-approved psychedelic treatment.
In the words of Leslie Knope: “Diabetes. Let’s dia-beat-this!”
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.